PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $124,000 | +49.4% | 27,944 | +66.3% | 0.00% | – |
| Q3 2021 | $83,000 | -73.8% | 16,800 | -63.9% | 0.00% | – |
| Q2 2021 | $317,000 | +7.5% | 46,491 | +7.8% | 0.00% | – |
| Q1 2021 | $295,000 | -15.5% | 43,115 | -23.5% | 0.00% | – |
| Q4 2020 | $349,000 | +200.9% | 56,340 | +165.8% | 0.00% | – |
| Q3 2020 | $116,000 | +31.8% | 21,200 | -1.9% | 0.00% | – |
| Q4 2019 | $88,000 | +41.9% | 21,600 | +61.1% | 0.00% | – |
| Q3 2019 | $62,000 | -63.3% | 13,407 | -57.3% | 0.00% | – |
| Q1 2019 | $169,000 | -27.2% | 31,400 | -29.9% | 0.00% | – |
| Q4 2018 | $232,000 | -45.7% | 44,800 | +1.7% | 0.00% | -100.0% |
| Q3 2018 | $427,000 | -40.8% | 44,044 | -20.5% | 0.00% | -50.0% |
| Q2 2018 | $721,000 | 0.0% | 55,370 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $721,000 | +65.7% | 55,370 | +127.9% | 0.00% | 0.0% |
| Q4 2017 | $435,000 | -63.2% | 24,300 | -48.4% | 0.00% | -60.0% |
| Q3 2017 | $1,181,000 | +22.5% | 47,085 | +24.3% | 0.01% | 0.0% |
| Q2 2017 | $964,000 | – | 37,872 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,387,172 | $6,537,000 | 1.72% |
| Worth Venture Partners, LLC | 969,698 | $2,366,000 | 1.39% |
| Omega Fund Management, LLC | 1,971,241 | $3,804,000 | 1.21% |
| Telemetry Investments, L.L.C. | 495,000 | $955,000 | 1.13% |
| CM Management, LLC | 350,000 | $676,000 | 0.72% |
| Bruce & Co., Inc. | 1,557,312 | $3,005,000 | 0.71% |
| Trellus Management Company, LLC | 295,000 | $569,000 | 0.69% |
| Abingworth LLP | 1,041,131 | $1,999,000 | 0.64% |
| 1492 Capital Management LLC | 489,376 | $944,000 | 0.62% |
| GENERAL AMERICAN INVESTORS CO INC | 1,752,470 | $3,382,000 | 0.34% |